Alaofi A
Molecules. 2022; 27(12).
PMID: 35745059
PMC: 9229102.
DOI: 10.3390/molecules27123936.
Carter E, Ang C, Chaiken I
Curr Protein Pept Sci. 2022; 24(1):59-77.
PMID: 35692162
PMC: 11660822.
DOI: 10.2174/1389203723666220610120927.
Marti-Mari O, Martinez-Gualda B, de la Puente-Secades S, Mills A, Quesada E, Abdelnabi R
J Med Chem. 2021; 64(14):10027-10046.
PMID: 34229438
PMC: 8389807.
DOI: 10.1021/acs.jmedchem.1c00315.
Curreli F, Ahmed S, Benedict Victor S, Iusupov I, Spiridonov E, Belov D
Bioorg Med Chem. 2021; 32:116000.
PMID: 33461144
PMC: 7856678.
DOI: 10.1016/j.bmc.2021.116000.
Aisenbrey C, Rifi O, Bechinger B
Sci Rep. 2020; 10(1):22278.
PMID: 33335248
PMC: 7746737.
DOI: 10.1038/s41598-020-79327-6.
Preclinical Optimization of gp120 Entry Antagonists as anti-HIV-1 Agents with Improved Cytotoxicity and ADME Properties through Rational Design, Synthesis, and Antiviral Evaluation.
Curreli F, Ahmed S, Benedict Victor S, Iusupov I, Belov D, Markov P
J Med Chem. 2020; 63(4):1724-1749.
PMID: 32031803
PMC: 7703574.
DOI: 10.1021/acs.jmedchem.9b02149.
Identification of a pH sensor in Influenza hemagglutinin using X-ray crystallography.
Antanasijevic A, Durst M, Lavie A, Caffrey M
J Struct Biol. 2019; 209(1):107412.
PMID: 31689502
PMC: 7111647.
DOI: 10.1016/j.jsb.2019.107412.
Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations.
Han Q, Jones J, Nicely N, Reed R, Shen X, Mansouri K
Nat Commun. 2019; 10(1):2898.
PMID: 31263112
PMC: 6602974.
DOI: 10.1038/s41467-019-10899-2.
Virtual Screening, Biological Evaluation, and 3D-QSAR Studies of New HIV-1 Entry Inhibitors That Function via the CD4 Primary Receptor.
Zhang C, Zhang H, Huang L, Zhu S, Xu Y, Zhang X
Molecules. 2018; 23(11).
PMID: 30463393
PMC: 6278378.
DOI: 10.3390/molecules23113036.
Potent suppression of HIV-1 cell attachment by Kudzu root extract.
Mediouni S, Jablonski J, Tsuda S, Richard A, Kessing C, Andrade M
Retrovirology. 2018; 15(1):64.
PMID: 30236131
PMC: 6149077.
DOI: 10.1186/s12977-018-0446-x.
Structure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120.
Curreli F, Belov D, Kwon Y, Ramesh R, Furimsky A, OLoughlin K
Eur J Med Chem. 2018; 154:367-391.
PMID: 29860061
PMC: 5993640.
DOI: 10.1016/j.ejmech.2018.04.062.
Development of peptide inhibitors of HIV transmission.
Shi S, Nguyen P, Cabral H, Diez-Barroso R, Derry P, Kanahara S
Bioact Mater. 2018; 1(2):109-121.
PMID: 29744399
PMC: 5883972.
DOI: 10.1016/j.bioactmat.2016.09.004.
HIV-1 gp41 transmembrane oligomerization monitored by FRET and FCS.
Schroeder S, Kaufman J, Grunwald M, Walla P, Lakomek N, Wingfield P
FEBS Lett. 2018; 592(6):939-948.
PMID: 29453892
PMC: 5996750.
DOI: 10.1002/1873-3468.13010.
HIV-1 envelope sequence-based diversity measures for identifying recent infections.
Kafando A, Fournier E, Serhir B, Martineau C, Doualla-Bell F, Sangare M
PLoS One. 2017; 12(12):e0189999.
PMID: 29284009
PMC: 5746209.
DOI: 10.1371/journal.pone.0189999.
Probing the metastable state of influenza hemagglutinin.
Kingsley C, Antanasijevic A, Palka-Hamblin H, Durst M, Ramirez B, Lavie A
J Biol Chem. 2017; 292(52):21590-21597.
PMID: 29127198
PMC: 5766969.
DOI: 10.1074/jbc.M117.815043.
HIV-1 envelope glycoprotein stimulates viral transcription and increases the infectivity of the progeny virus through the manipulation of cellular machinery.
Ran X, Ao Z, Trajtman A, Xu W, Kobinger G, Keynan Y
Sci Rep. 2017; 7(1):9487.
PMID: 28842659
PMC: 5573355.
DOI: 10.1038/s41598-017-10272-7.
The CpG dinucleotide content of the HIV-1 envelope gene may predict disease progression.
Wasson M, Borkakoti J, Kumar A, Biswas B, Vivekanandan P
Sci Rep. 2017; 7(1):8162.
PMID: 28811638
PMC: 5557942.
DOI: 10.1038/s41598-017-08716-1.
Native structure of a retroviral envelope protein and its conformational change upon interaction with the target cell.
Riedel C, Vasishtan D, Siebert C, Whittle C, Lehmann M, Mothes W
J Struct Biol. 2016; 197(2):172-180.
PMID: 27345930
PMC: 5182179.
DOI: 10.1016/j.jsb.2016.06.017.
Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41.
Yi H, Fochtman B, Rizzo R, Jacobs A
Curr HIV Res. 2016; 14(3):283-94.
PMID: 26957202
PMC: 4909398.
DOI: 10.2174/1570162x14999160224103908.
Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions.
Antanasijevic A, Kingsley C, Basu A, Bowlin T, Rong L, Caffrey M
J Biomol NMR. 2016; 64(3):255-65.
PMID: 26921030
PMC: 4826305.
DOI: 10.1007/s10858-016-0025-1.